title: Why use Markov simulation models for estimating the effect of cancer screening policies when randomised controlled trials provide better evidence?
authors.forename: Alain
authors.initials: A
authors.lastname: Braillon
authors.forename: Susan
authors.initials: S
authors.lastname: Bewley
mesh_terms: D001943:Breast Neoplasms / Q000175:diagnosis*; D006801:Humans; D008390:Markov Chains; D015233:Models, Statistical